Srx Health Solutions Inc (SRXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,040 | N/A | 8,470 | 11,926 | -12,850 |
| Depreciation Amortization | 409 | N/A | 3,931 | 2,601 | 411 |
| Accounts receivable | -2,925 | N/A | -2,893 | -558 | -2,044 |
| Accounts payable and accrued liabilities | 728 | N/A | -8 | 328 | N/A |
| Other Working Capital | -5,364 | N/A | -950 | 601 | 424 |
| Other Operating Activity | 3,525 | 0 | -16,870 | -19,560 | 11,734 |
| Operating Cash Flow | $-7,667 | $N/A | $-8,320 | $-4,662 | $-2,325 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -150 | N/A | -124 | -54 | N/A |
| Investing Cash Flow | $-150 | $N/A | $-124 | $-54 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,500 | N/A | 5,535 | 5,155 | 5,155 |
| Debt Issued | N/A | N/A | 6,000 | 6,000 | 6,000 |
| Debt Repayment | -200 | N/A | -8,379 | -8,229 | -8,080 |
| Common Stock Issued | N/A | N/A | 41,857 | 3,993 | 4,012 |
| Common Stock Repurchased | N/A | N/A | -1,274 | N/A | N/A |
| Other Financing Activity | -7 | 0 | -6,023 | -3,645 | -4,390 |
| Financing Cash Flow | $2,293 | $N/A | $37,716 | $3,274 | $2,697 |
| Beginning Cash Position | 28,942 | N/A | 3,989 | 3,989 | 3,989 |
| End Cash Position | 23,418 | N/A | 33,261 | 2,547 | 4,361 |
| Net Cash Flow | $-5,524 | $N/A | $29,272 | $-1,442 | $372 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,667 | N/A | -8,320 | -4,662 | -2,325 |
| Capital Expenditure | -150 | N/A | -124 | -54 | N/A |
| Free Cash Flow | -7,817 | 0 | -8,444 | -4,716 | -2,325 |